Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf3. , Rh-;
4." ;
5.# " ;
6.& ?@.
:
& :
1.L " # <100 ;
2.L " # >180 ;
3.? ;
4.@ ( );
% ; 1. ? 7 % ;
2.+ " % ( , , );
3.+ <7,0;
4.@ % # " >16 &/ .
5." + <7,0;
6. ? 3 , $# " 5 ;
7." % " % &
|
( |
, , ); |
|
|
|
|
|
||
8. |
& " & . |
||||||||
" & : |
|
|
|
||||||
1. |
H % |
|
|
& |
|
||||
|
" & |
; |
|
|
|
||||
2. |
|
|
% |
|
|
, |
|
||
|
|
|
|
|
|
|
3 |
||
" $ ;
3.' $ & % 15 ;
" & & :
1.' % & ,, &3 $;
2.B % # " ; , .
+ :
:
1.&% 30 ;
2.& &
&$ ;
3.& " , % " ," & &
% ; 4. % & & :
-< & , & " , & 3 ;
-;
-% ;
5.% & "
& |
|
$# % 15 $ |
||||||
% 5 II & |
||||||||
& &$ ; |
|
|
|
|
|
|||
2. & |
|
" & |
(" |
" |
||||
# 110-160 |
|
, |
) |
& $ |
||||
" |
: |
|
|
|
|
|
||
- % & |
"$ &$ ; |
|
||||||
- ! & |
% & $ |
( |
|
|||||
, & # # ). |
|
|
|
|||||
3. |
" |
% & $: |
||||||
- & |
; |
|
|
|
||||
- % |
" ; |
|
|
|
||||
- B : & , ?@, |
; |
|
||||||
-' # .
4." , & :
-H " ;
-B , "$# " – 5%$, , .
-H & & .
; :
- % , "$# "- &$#$ ;
-B$" , , " , % % ;
-/ ;
< |
: |
|
- |
% |
, "$# "- |
&$#$ |
; |
|
- # ; - # % ;
-" % &$ 8-10 ;
-/ ;
-B & , ?@ % .
3 , 3. ", "% .
" & :
1.*$ 5%, 10% 400 , 500
2.* @ "& V 40 /10%, 20%
3.*
" & & :
|
,- ! : |
L " # 110-160 ; |
|
? ( ); |
|
|
? 7 % ; |
+ " % $;
+ >7,0; ! % # " <16 &/ .
/ , & :
1.SOGC Clinical Practice Guidelines: Fetal Health Surveillance in Labour.- #112, April, 2002.- p.7
2.SOGC Clinical Practice Guidelines: Fetal Health Surveillance in Labour.- #112, March, 2002.- p.13
3.SOGC Clinical Practice Guidelines: Attendance at Labour and Delivery Guidelines for Obstetrical Care.- #89, May, 2000.- p.3
4.RCOG: Setting Standarts to Improve Women’s Health. Induction of Labour. Evidence-based Clinical Guideline #9, 2001, p.78
5.Institute for Clinical Systems Improvement. Health Care Guideline. Rutine Prenatal Care, 2005, p.80
6.National Collaborating Center for Women’s and Children’s Health. Antenatal Care: Rutine Care for the Healthy Pregnant Women. Clinical Guideline, 2003, p.286
7." & – ? , 2004 . ! 109126.
* – , # (% % )
( 8
: 13-125
"$ &: -" :
& !: & , , ,
' & & : 8
(:
N75 < %
N75.0 %
N75.1 ? %
N75.8 @ %
N75.9 < & % "
) : ( – % . |
|
|
|
|||
# - " % |
& % |
|||||
" |
. ' % |
. |
_ |
|||
|
|
|
|
% |
|
|
& , . |
|
|||||
% |
|
|
|
|
||
|
, % |
3 |
||||
. % & & & " . & % & [ %$# $. [% " .
$ :
1.<
2.?
3.%
* :
1.!
2.+ " B
" :
" :
% ,
% ,
3 & " % .
5 :
& RW
# # " 6 & "
< & HbsAg
? HCV
:
1.& .
2.< &.
3..
4..
5.$, . @ & :
- B & .
- B & % [ (% [ ! ), % & .
" & :
1.#
2.# "
3.6 & "
4.< " & &
5.(B_?, / ) , ,
" & & :
1.HbsAg
2.? HCV
+ :
" . ?
— " $ & % # &. @ 3 &$ $ $. '
" & ( . % ).
-? " $ ; & .
-? & , :
• & ;
• % ;
• & .
- B & % " & I () 500 3 400 3 " 10 .
- > , & . 6 % " & &$ $ & & & + '!, % $[ . & &
$ . |
|
|
|
|
|
|
|
|
|
J " % , |
" $ |
|||
|
, |
. |
|
|
• |
|
" |
||
% |
. " & [ |
|||
$ , " & & |
1,5 . |
|||
) "$ % |
$ %$# % |
|||
" . |
|
|
|
|
- ' % & . @
" . |
|
|
|
+$ |
|
|
|
- |
" 1 . ' & $ |
||
% % & |
#&$ " |
||
& . |
|
|
|
- $# |
% |
||
% & & |
$ |
||
% |
. |
|
|
" & : |
|
|
|
1. */ , 250 , 500 ; |
125 , 250 /5 |
||
2.*6 250 0,5 100
3.*_ 50 , 150 ; / 100
4., 400
5.*+ , 500
6.*6 , 0,5 100
7.*@ ,
" & & :
,- ! :
% |
" % |
/ , |
& : |
1.Candidiasis (vulvovaginal) Search date November 2004 Clinical Evidence is a website owned by BMJ Publishing Group Limited, incorporated in the United Kingdom, company registration number 3012371. Their registered office is situated at BMA House, Tavistock Square, London WC1H 9JP. VAT Number 674738491.
2.Oral fluconazole Search date November 2004 Clinical Evidence is a website owned by BMJ Publishing Group Limited, incorporated in the United Kingdom, company registration number 3012371. Their registered office is situated at BMA House, Tavistock Square, London WC1H 9JP. VAT Number 674738491.
3." , & : . . /. M.J. K " , B.+. @ , '.B. , .6. G . — 2- ., . — 6.: 7 ;? -6>@, 2002. — 1248 .: .
* – , # (% % )
' , $ , 8 ,- |
|
&, |
|
: 14-132% |
|
"$ &: -" |
|
: |
|
& ! : ! |
" 3 & , |
%$# &, , # .
H " |
, " , |
% |
. |
' & & :10-14
(:
O99 @ , , %$# &,
" : 3 $" , %$# &, #
&$ $# |
" |
# |
||
? |
& XV. |
|||
B$" : |
|
|
|
|
(O98.-) |
|
|
||
" , " |
# $ , |
|||
|
, " $ (O35-O36) |
|||
, |
|
" (S00- |
||
T98) |
|
|
|
|
O99.2 < 3 , |
# , |
|||
%$# &, |
|
|
|
|
B$" : |
|
|
|
|
" & (O25) |
|
|
|
|
(O90.5) |
|
|
|
|
(O24.-) |
|
|
|
|
O99.3 " , %$# &, |
||||
|
|
|
|
|
B$" : |
|
|
|
|
(F53.1) |
|
|
|
|
& (F53.0) |
|
|
|
|
&$ % |
" (O26.8) |
|
||
O99.4 < # , %$# &, |
|
|||
|
|
|
|
|
B$" : |
|
|
|
|
3 (O88.-)
% : - (O22.-)
- (O87.-)(O10-O16)
(O90.3)
O99.5 |
< , %$# &, |
||
O99.6 |
< |
# , %$# &, % |
|
|
|
|
|
B$" : |
% |
" , |
|
(O26.6) |
|
|
|
O99.7 |
< % % " , %$# &, % |
||
|
|
|
|
B$" : (O26.4)
O99.8 @ " , %$# &, %
B$" : |
|
|
|
|
|
" |
(O23.-) |
|
|
|
|
#& |
|||||
(O34.-) |
|
|
|
|
|
" " " & (O90.4) |
|
|
|
||
) : @ |
, |
|
" , |
|
|
. |
|
|
|
|
|
$ : @ |
, |
|
" , |
|
|
. |
|
|
|
|
|
* : |
|
|
|
|
|
$# " ; |
|
|
|
||
+ # ; |
|
|
|
||
+ &; |
|
|
|
|
|
' " : , &, ; |
|
|
|
||
! ; |
|
|
|
|
|
+ &-3 " . |
|
|
|
||
" : |
|
|
|
|
|
" |
: |
|
|
|
|
|
% ; |
|
|
||
|
3 & ; |
|
|
|
|
|
; |
|
|
|
|
@ ( ).
|
5 : |
|
||||
- |
, Rh-; |
|
|
|
||
-# ; |
|
|
|
|
||
-" ; |
|
|
||||
- HbsAg; |
|
|
|
|
||
- 'BL; |
|
|
|
|
||
-# " ; |
|
|
|
|
||
-" 3 " ; |
|
|
|
|||
-& ?@; |
|
|
|
|||
- |
. |
|
|
|
|
|
-? HCV. |
|
|
|
|
||
|
|
: ! 3 & , %$# |
||||
&, |
|
|
|
|||
" & : |
|
|||||
-# ; |
|
|
|
|
||
-; |
|
|
|
|
||
- ; |
|
|
|
|
||
-H)B |
; |
|
|
|
|
|
- |
" |
|
"- |
- |
|
|
$# : |
|
|
|
|||
|
- " ; |
|
|
|
||
|
- " ; |
|
|
|
||
|
- |
; |
|
|
||
|
- " % |
" |
||||
|
; |
|
|
|
|
|
" & & : &$ % $# .
HbsAg ? HCV
+ : ;% .
" & : " & & :
,- ! :
3 & .
/ , & :
1.Institute for Clinical Systems Improvement. Health Care Guideline. Rutine Prenatal Care, 2005, p.80
2.National Collaborating Center for Women’s and Children’s Health. Antenatal Care: Rutine Care for the Healthy Pregnant Women. Clinical Guideline, 2003, p.286
3.National Guideline Clearinghouse: DoD/VA Clinical Practice Guideline for Managment of Uncomplicated Pregnancy, 2002. p.20
* – , # (% % )
'
: 14-130
"$ &: -" :
& ! : & , , " , % ,, %
' & & : 5
(: 05 @ ) : & - " % , $#
& , " $ - 3 " .
$ : # .
* :
+ &-3 " &;
|
+ |
& ; |
|
+ |
& & ; |
|
' |
18 ; |
" : 3
5 : H" 3
|
, |
& . |
|||||
|
|
& |
|
||||
|
$ % # . |
|
|
||||
|
|
|
: |
|
|
|
|
1. |
H ( " |
|
|||||
|
% " ); |
|
|
||||
2. |
H % |
(H)B); |
|||||
3. |
' % |
" ; |
|||||
4. |
' % |
- & |
" ; |
||||
5. |
" % & . |
|
|||||
" & : |
|
||||||
1. |
H |
; |
|||||
2. |
% " " ; |
||||||
3. |
|
Rh- |
; |
|
|||
4.H)B & " ;
5.# ( , , , , );
6.;
7.B 'BL;
8.B ;
9.# " ;
10.6 & " .
" & & :
1.7 ;
2.& ;
3.HbsAg, ? HCV.
+ : " "& " () & H)B.
6 ", % % " % " . &